Chemesis International Inc. Receives Hemp Licensing in Central United States
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. Receives Hemp Licensing in Central United States
In continuing efforts to expand its U.S. footprint, Chemesis receives Hemp Cultivation & Processing Licenses in
Michigan
June 20, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces it has received its Hemp Cultivation & Processing Licenses (“Licenses”) in the
state of Michigan. With these licenses, the Company will begin its ini tial planting process in the coming
weeks. These Licenses are a significant step forward in Chemesis’ long term goals of establishing itself as
a major cannabis multi -state operator. The Company will also continue to evaluate assets and apply for
licensing in the previously announced states such as Wisconsin, Illinois, Missouri, and Michigan.
In receiving these licenses, Chemesis now has US operations in California, Arizona, Puerto Rico and
Michigan. The Companies long term growth strategy involves continuing to expand into other states with
favourable regulations and assets that compliment Chemesis’ current operations and capabilities . The
Company anticipates favourable regulations on both the state and federal level, and will continue to
execute a strategy that will bring long term growth and shareholder value.
The state of Michigan passed the Michigan Regulation and Taxation of Marijuana Act (“MRTMA”) on
November 6, 2018, which delegated responsibility for regulation, licensing, and enforcement for oversight
for both medical and recreational use of cannabis. Michigan is projected to be in the top five of largest
medical cannabis markets in the U.S. The total legal market is expected to be USD $755.7 million by 2020,
with a CAGR of 7%.1
“We are very pleased to have received a Hemp Cultivation License for the state of Michigan,” said CEO of
Chemesis, Edgar Montero. “Michigan is a large cannabis market and the Company believes building a
major footprint in the state will not only increase revenues and long -term growth, but bring even bigger
opportunities across the United States. The e xpansion also allows the Company to bring its products to
consumers throughout the United States.”
Additional information on Chemesis International's Michigan operations will be announced in the near
future.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
1 New Frontier Data – 2018 Industry Outlook
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. is a vertically integrated U.S. Multi -State operator with International
operations in Puerto Rico, and Colombia.
The Company focuses on prudent capital allocation to ens ure it maintains a first mover advantage as it
enters new markets and is committed to differentiate itself by deploying resources in markets with major
opportunities. The Company operates a portfolio of brands which cater to a wide community of cannabis
consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California, and is in the process of constructing a GMP
certified facility in Colombia. Chemesis’ Puerto Rico operations are licensed to operate 100,000 ft 2 of
cultivation, and 35,000 ft 2 of manufacturing floor space. The Company is positioned to win additional
licenses in highly competitive merit-based US states, and will expand its footprint to ensure it maintains a
first mover advantage.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within t he meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, including finalizing an acquisition in
Colombia. Although the Company believes that the expectations reflected in the forward -looking information are
reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to
place undue reliance on forward -looking info rmation. Such forward -looking statements are subject to risks and
uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by these statements depending on, among other things, the risks that th e Company's products and
plan will vary from those stated in this news release and the Company may not be able to carry out its business plans
as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update
any forward-looking statements or forward-looking information in this news release. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, there can be no assurance that
such expectations will p rove to be correct and makes no reference to profitability based on sales reported. The
statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release